New shot aims to tame COPD Flare-Ups
NCT ID NCT07418736
Summary
This study is testing an investigational antibody injection called CM326 for people with moderate-to-severe chronic obstructive pulmonary disease (COPD). The main goal is to see if the injection can reduce the number of serious symptom flare-ups (called exacerbations) and improve lung function and quality of life. About 318 participants will receive either the real injection or a placebo (a dummy shot) for 24 to 52 weeks to compare results.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC OBSTRUCTIVE PULMONARY DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
China-Japan Friendship Hospital
RECRUITINGBeijing, Beijing Municipality, 100000, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.